Bio-Techne (TECH) Non-Current Deferred Tax Liability (2016 - 2026)
Bio-Techne has reported Non-Current Deferred Tax Liability over the past 15 years, most recently at $11.0 million for Q4 2025.
- For Q4 2025, Non-Current Deferred Tax Liability fell 70.78% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, down 70.78%, while the annual FY2025 figure was $6.2 million, 88.96% down from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 was $11.0 million at Bio-Techne, down from $11.3 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $112.9 million in Q3 2022 and troughed at $4.1 million in Q3 2023.
- A 5-year average of $67.1 million and a median of $80.3 million in 2023 define the central range for Non-Current Deferred Tax Liability.
- Biggest five-year swings in Non-Current Deferred Tax Liability: plummeted 96.37% in 2023 and later surged 1119.93% in 2024.
- Year by year, Non-Current Deferred Tax Liability stood at $101.4 million in 2021, then increased by 9.82% to $111.4 million in 2022, then tumbled by 35.74% to $71.6 million in 2023, then tumbled by 47.3% to $37.7 million in 2024, then tumbled by 70.78% to $11.0 million in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for TECH at $11.0 million in Q4 2025, $11.3 million in Q3 2025, and $6.2 million in Q2 2025.